Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Brain Neoplasms 4Neoplasms 2Breast Neoplasms 2Sarcoma 1Prostatic Neoplasms 1Pituitary Neoplasms 1Osteosarcoma 1Oligodendroglioma 1Neurotoxicity Syndromes 1Neurofibromatosis 1 1Neuroendocrine Tumors 1Neoplasm Metastasis 1Multiple Myeloma 1Meningioma 1Lymphoma, Non-Hodgkin 1Lymphoma, B-Cell 1Lung Neoplasms 1Hodgkin Disease 1Glioma 1Glioblastoma 1Fatigue 1Cytokine Release Syndrome 1Colorectal Neoplasms 1Carcinoma, Hepatocellular 1Astrocytoma 1

Interventions

Temozolomide 393Radiotherapy 196Bevacizumab 156Radiation 77Magnetic Resonance Spectroscopy 68Lomustine 47Surgical Procedures, Operative 42Carmustine 41pembrolizumab 39Irinotecan 38Nivolumab 32Specimen Handling 27Carboplatin 27Radiosurgery 24Erlotinib Hydrochloride 24Chemotherapy, Adjuvant 23Radiotherapy, Intensity-Modulated 22Drug Therapy 21Cyclophosphamide 20Aminolevulinic Acid 20O(6)-benzylguanine 17sargramostim 16Radiotherapy, Conformal 15temsirolimus 14Granulocyte-Macrophage Colony-Stimulating Factor 14Everolimus 14Vorinostat 13Sorafenib 13poly ICLC 12atezolizumab 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Glioblastoma × Neuropsychological Tests × Clear all
NCT01854554 2024-01-02

Glioblastoma Multiforme (GBM) Proton vs. Intensity Modulated Radiotherapy (IMRT)

M.D. Anderson Cancer Center

Phase 2 Completed
90 enrolled 11 charts
CNS

Brain Neoplasms, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡